Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18223096rdf:typepubmed:Citationlld:pubmed
pubmed-article:18223096lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C0521425lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C0034804lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:18223096lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:18223096pubmed:issue2lld:pubmed
pubmed-article:18223096pubmed:dateCreated2008-1-28lld:pubmed
pubmed-article:18223096pubmed:abstractTextThe majority of all breast cancers are hormone responsive, traditionally defined by the expression of oestrogen receptor (ER) alpha and/or progesterone receptors. In contrast to ERalpha, the clinical significance of the relatively recently identified ERbeta is still unclear. This study aimed to define the relationship between ERbeta and clinicopathological parameters in a mixed cohort of breast cancer and, furthermore, to investigate the impact of ERbeta expression on disease outcome.lld:pubmed
pubmed-article:18223096pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18223096pubmed:languageenglld:pubmed
pubmed-article:18223096pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18223096pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18223096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18223096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18223096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18223096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18223096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18223096pubmed:statusMEDLINElld:pubmed
pubmed-article:18223096pubmed:monthFeblld:pubmed
pubmed-article:18223096pubmed:issn1472-4146lld:pubmed
pubmed-article:18223096pubmed:authorpubmed-author:HoltDDlld:pubmed
pubmed-article:18223096pubmed:authorpubmed-author:AnagnostakiLLlld:pubmed
pubmed-article:18223096pubmed:authorpubmed-author:LandbergGGlld:pubmed
pubmed-article:18223096pubmed:authorpubmed-author:JirströmKKlld:pubmed
pubmed-article:18223096pubmed:authorpubmed-author:StendahlMMlld:pubmed
pubmed-article:18223096pubmed:authorpubmed-author:BorgquistSSlld:pubmed
pubmed-article:18223096pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18223096pubmed:volume61lld:pubmed
pubmed-article:18223096pubmed:ownerNLMlld:pubmed
pubmed-article:18223096pubmed:authorsCompleteYlld:pubmed
pubmed-article:18223096pubmed:pagination197-203lld:pubmed
pubmed-article:18223096pubmed:dateRevised2008-10-21lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:meshHeadingpubmed-meshheading:18223096...lld:pubmed
pubmed-article:18223096pubmed:year2008lld:pubmed
pubmed-article:18223096pubmed:articleTitleOestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.lld:pubmed
pubmed-article:18223096pubmed:affiliationDivision of Pathology, Department of Laboratory Medicine; Malmö University Hospital, Malmö, Sweden.lld:pubmed
pubmed-article:18223096pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18223096pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18223096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18223096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18223096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18223096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18223096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18223096lld:pubmed